Sort
261,768 grants matching “gene therapy”
Animal Models of Diabetic Vascular Disease
$884,399Rockefeller University · U01 · FY2003 · HL
Discovery of Molecules to disrupt the outer membrane of Gram-negative pathogens
$884,388Daniel E Kahne · Harvard Medical School · U19 · FY2018 · AI
WASHINGTON UNIVERSITY PAUL CALABRESI CAREER DEVELOPMENT AWARD FOR CLINICAL ONCOLO
$884,381Ramaswamy Govindan · Washington University · K12 · FY2014 · CA
Deciphering how 3D genome organization orchestrates cardiac cellular identity
$884,375Rajan Jain · University Of Pennsylvania · R35 · FY2023 · HL
Therapeutic use of an enhanced form of CD4-Ig
$884,356Michael R. Farzan · Boston Children'S Hospital · R37 · FY2025 · AI
Therapeutic use of an enhanced form of CD4-Ig
$884,320Michael R. Farzan · Boston Children'S Hospital · R37 · FY2024 · AI
Prevention of Graft-Versus-Host-Disease in the Era of Adoptive Immunotherapy
$884,291Marie Bleakley · Fred Hutchinson Cancer Research Center · P01 · FY2020 · CA
The integrated stress response in cognitive disorders
$884,285Paul Pfaffinger · Baylor College Of Medicine · R01 · FY2023 · NS
Making hypomorphic tumor supressors in vivo using RNAi
$884,222Scott W Lowe · Cold Spring Harbor Laboratory · U01 · FY2007 · CA
Pharmacogenomics to Catalyze Decision Support in Oncology Care
$884,216Peter Hugh O'Donnell · University Of Chicago · R01 · FY2023 · HG
Molecular dissecting and targeting YAP1 mediated cancer stemness and immune suppression in advanced gastric adenocarcinoma
$884,176Shumei Song · Coriell Institute For Medical Research · R01 · FY2025 · CA
Development of a companion diagnostic to identify patients who respond to microbiome-targeting drugs
$884,165Bret David Wallace · Symberix, Inc. · R44 · FY2020 · GM
Mechanisms of ubiquitin signaling in chromatin-mediated processes
$884,163Cynthia Wolberger · Johns Hopkins University · R35 · FY2020 · GM
CVD in American Indians Study and Data Management Center and OK Field Center
$884,135Elisa Lee · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2015 · HL
Studies of Populations Exposed to Occupational Sources of Radiation
$884,081Martha S Linet · Division Of Cancer Epidemiology And Genetics · Z01 · FY2008 · CA
One-click Automated 3D Treatment Planning for Radiopharmaceutical Therapy
$883,986Paul Wickre · Voximetry, Inc. · R44 · FY2020 · CA
Making hypomorphic tumor supressors in vivo using RNAi
$883,896Scott W Lowe · Cold Spring Harbor Laboratory · U01 · FY2006 · CA
Gene Expression and Diagnosis of Autoimmune Disease
$883,821Thomas M. Aune · Arthrochip, Llc · R42 · FY2009 · AI
Gene Expression and Diagnosis of Autoimmune Disease
$883,821Thomas M. Aune · Arthrochip, Llc · R42 · FY2008 · AI
Gene Expression and Diagnosis of Autoimmune Disease
$883,821Thomas M. Aune · Arthrochip, Llc · R42 · FY2010 · AI
Systematic Characterization and Targeting of Neomorphic Drivers in Cancer
$883,656Gordon B. Mills · Oregon Health & Science University · U01 · FY2023 · CA
Functional consequences of intergenic autoimmune disease risk variants
$883,641Timothy B Niewold · Hospital For Special Surgery · R01 · FY2023 · AI
Molecular Biology of the Metastatic Phenotype
$883,640Patricia Schriver Steeg · Division Of Clinical Sciences - Nci · ZIA · FY2014 · CA
Molecular Analysis of Breast Cancer Metastasis to the Brain
$883,640Patricia Schriver Steeg · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
A Safety and Efficacy study of AAV2-hAADC for AADC deficiency
$883,538Krystof S Bankiewicz · University Of California, San Francisco · R01 · FY2017 · NS